Aripiprazole Long-Acting Injections Improved Control of Parkinson's Disease

Am J Ther. 2022 May-Jun;29(3):e379-e380. doi: 10.1097/MJT.0000000000001269. Epub 2020 Oct 1.

Authors

Yu-Ning Her¹, Chun-Yen Chen¹, Hsin-An Chang^{1

2}, Yu-Chen Kao^{1

3}, Fan-Jung Wan¹, Nian-Sheng Tzeng^{1

2}

Affiliations

¹ Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan.
² Student Counseling Center, National Defense Medical Center, Taipei, Taiwan.
³ Department of Psychiatry, Tri-Service General Hospital, Song-Shan Branch, National Defense Medical Center, Taipei, Taiwan.

PMID: 33021527
DOI: 10.1097/MJT.0000000000001269

No abstract available

Publication types

Letter

MeSH terms

Antipsychotic Agents* / therapeutic use
Aripiprazole
Delayed-Action Preparations
Humans
Parkinson Disease* / drug therapy

Substances

Antipsychotic Agents
Delayed-Action Preparations
Aripiprazole